{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:29:14Z","timestamp":1765888154921,"version":"3.37.3"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009575","name":"Jacques and Gloria Gossweiler Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009575","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Exercise is emerging as an important aspect in the management of disease-related symptoms and functional decline in people with Huntington disease (HD). Long-term evaluation of physical activity and exercise participation in HD has yet to be undertaken.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The objective is to investigate the feasibility of a nested randomized controlled trial (RCT) alongside a longitudinal observational study of physical activity and exercise outcomes in people with HD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>This will be a 12-month longitudinal observational study (n\u00a0=\u00a0120) with a nested evaluation of a physical activity intervention (n\u00a0=\u00a030) compared with usual activity (n\u00a0=\u00a030) using a \u201ctrial within a cohort\u201d design.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>The study will take place in HD specialist clinics in Germany, Spain, and the United States, with intervention delivery in community settings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>The participants will have early-mid\u2013stage HD and be participating in the Enroll-HD study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Intervention<\/jats:title>\n                  <jats:p>This will be a 12-month physical activity behavioral change intervention, delivered by physical therapists in 18 sessions, targeting uptake of aerobic exercise and increased physical activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Measurements<\/jats:title>\n                  <jats:p>All participants (n\u00a0=\u00a0120) will complete Enroll-HD assessments (motor, cognitive, behavioral, and quality of life) at baseline and at 12 months. Additional Physical ACtivity and Exercise Outcomes in Huntington Disease (PACE-HD) assessments include fitness (predicted maximal oxygen uptake [V\u2009\u2009o2max]), self-reported and quantitative measures of physical activity, disease-specific symptoms, and walking endurance. RCT participants (n\u00a0=\u00a060) will complete an additional battery of quantitative motor assessments and a 6-month interim assessment. Enroll-HD data will be linked to PACE-HD physical activity and fitness data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Limitations<\/jats:title>\n                  <jats:p>The limitations include that the embedded RCT is open, and assessors at RCT sites are not blinded to participant allocation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>PACE-HD will enable determination of the feasibility of long-term physical activity interventions in people with HD. The novel \u201ctrial within a cohort\u201d design and incorporation of data linkage have potential to reduce participant burden. This design could be applied to other neurological diseases and movement disorders where recruitment and retention are challenging.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ptj\/pzz075","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T11:27:44Z","timestamp":1558006064000},"page":"1201-1210","source":"Crossref","is-referenced-by-count":10,"title":["Physical Activity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington Disease"],"prefix":"10.1093","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4397-6252","authenticated-orcid":false,"given":"Cheney J G","family":"Drew","sequence":"first","affiliation":[{"name":"Centre for Trials Research, Cardiff University, South Glamorgan, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Quinn","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University; and Teachers College, Columbia University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katy","family":"Hamana","sequence":"additional","affiliation":[{"name":"School of Health Care Sciences, Cardiff University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhys","family":"Williams-Thomas","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, South Glamorgan, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Marsh","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, South Glamorgan, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polyxeni","family":"Dimitropoulou","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, South Glamorgan, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Playle","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, South Glamorgan, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth Ann","family":"Griffin","sequence":"additional","affiliation":[{"name":"RAND Corporation, Arlington, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Kelson","sequence":"additional","affiliation":[{"name":"Department of Mathematics, University of Exeter, Exeter, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Schubert","sequence":"additional","affiliation":[{"name":"George Huntington Institute and Institute for Clinical Radiology, University of M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Muratori","sequence":"additional","affiliation":[{"name":"George Huntington Institute and Institute for Clinical Radiology, University of M\u00fcnster; and School of Health Technology and Management, Stony Brook University, Stony Brook, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Reilmann","sequence":"additional","affiliation":[{"name":"George Huntington Institute and Institute for Clinical Radiology, University of M\u00fcnster; and Department of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Rosser","sequence":"additional","affiliation":[{"name":"School of Bioscience, Cardiff University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Busse","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, 4th Floor, Neuadd Meirionydd Health Park, Cardiff, South Glamorgan CF14 7YS, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"2023012004010694700_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-971176","article-title":"Huntington's disease","volume":"27","author":"Walker","year":"2007","journal-title":"Semin Neurol"},{"key":"2023012004010694700_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/mds.1056","article-title":"Impact of Huntington's disease on quality of life","volume":"16","author":"Helder","year":"2001","journal-title":"Mov Disord"},{"key":"2023012004010694700_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/scs.12098","article-title":"Caregiver roles in families affected by Huntington's disease: a qualitative interview study","volume":"28","author":"R\u00f8thing","year":"2014","journal-title":"Scand J Caring Sci"},{"key":"2023012004010694700_bib4","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/ene.13107","article-title":"The societal cost of Huntington's disease: are we underestimating the burden?","volume":"23","author":"Jones","year":"2016","journal-title":"Eur J Neurol"},{"key":"2023012004010694700_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neubiorev.2015.03.003","article-title":"Environmental factors as modulators of neurodegeneration: insights from gene-environment interactions in Huntington's disease","volume":"52","author":"Mo","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"2023012004010694700_bib6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1474-4422(13)70123-6","article-title":"Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease","volume":"12","author":"Petzinger","year":"2013","journal-title":"Lancet Neurol"},{"key":"2023012004010694700_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0269215512473762","article-title":"What effect does a structured home-based exercise programme have on people with Huntington's disease? A randomized, controlled pilot study","volume":"27","author":"Khalil","year":"2013","journal-title":"Clin Rehabil"},{"key":"2023012004010694700_bib8","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2522\/ptj.20140123","article-title":"Task-specific training in Huntington disease: a randomized controlled feasibility trial","volume":"94","author":"Quinn","year":"2014","journal-title":"Phys Ther"},{"key":"2023012004010694700_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.parkreldis.2016.06.023","article-title":"A randomized, controlled trial of a multi-modal exercise intervention in Huntington's disease","volume":"31","author":"Quinn","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"2023012004010694700_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/NPT.0000000000000016","article-title":"A randomized feasibility study of a 12-week community-based exercise program for people with Huntington's disease","volume":"37","author":"Busse","year":"2013","journal-title":"J Neurol Phys Ther"},{"key":"2023012004010694700_bib11","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1177\/0269215513487235","article-title":"Video game play (Dance Dance Revolution) as a potential exercise therapy in Huntington's disease: a controlled clinical trial","volume":"27","author":"Kloos","year":"2013","journal-title":"Clin Rehabil"},{"key":"2023012004010694700_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-170260","article-title":"Physical therapy and exercise interventions in Huntington's disease: a mixed methods systematic review","volume":"6","author":"Fritz","year":"2017","journal-title":"J Huntingtons Dis"},{"key":"2023012004010694700_bib13","doi-asserted-by":"crossref","first-page":"c1066","DOI":"10.1136\/bmj.c1066","article-title":"Rethinking pragmatic randomised controlled trials: introducing the \u201ccohort multiple randomised controlled trial\u201d design","volume":"340","author":"Relton","year":"2010","journal-title":"BMJ"},{"volume-title":"Homepage","author":"Enroll-HD","key":"2023012004010694700_bib14"},{"author":"Enroll-HD","key":"2023012004010694700_bib15","article-title":"Access data, biosamples and clinical rater training"},{"author":"Enroll-HD","key":"2023012004010694700_bib16","article-title":"A prospective registry study in a global Huntington's disease cohort"},{"key":"2023012004010694700_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2018.00366","article-title":"Rethinking functional outcome measures: the development of a novel upper limb token transfer test to assess basal ganglia dysfunction","volume":"12","author":"Clinch","year":"2018","journal-title":"Front Neurosci"},{"key":"2023012004010694700_bib18"},{"key":"2023012004010694700_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/B978-0-12-801893-4.00018-3","article-title":"Motor outcome measures in Huntington disease clinical trials","volume":"144","author":"Reilmann","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"2023012004010694700_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/ptj\/pzx031","article-title":"Physical activity self-management and coaching compared to social interaction in Huntington disease: results from the ENGAGE-HD randomized, controlled pilot feasibility trial","volume":"97","author":"Busse","year":"2017","journal-title":"Phys Ther"},{"key":"2023012004010694700_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/1745-6215-15-487","article-title":"Supporting physical activity engagement in people with Huntington's disease (ENGAGE-HD): study protocol for a randomized controlled feasibility trial","volume":"15","author":"Busse","year":"2014","journal-title":"Trials"},{"key":"2023012004010694700_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1479-5868-9-78","article-title":"Exercise, physical activity, and self-determination theory: a systematic review","volume":"9","author":"Teixeira","year":"2012","journal-title":"Int J Behav Nutr Phys Act"},{"key":"2023012004010694700_bib23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3109\/09638280903362712","article-title":"Client and therapist views on exercise programmes for early-mid stage Parkinson's disease and Huntington's disease","volume":"32","author":"Quinn","year":"2010","journal-title":"Disabil Rehabil"},{"key":"2023012004010694700_bib24","doi-asserted-by":"crossref","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"key":"2023012004010694700_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/NPT.0000000000000119","article-title":"Development and delivery of a physical activity intervention for people with Huntington disease: facilitating translation to clinical practice","volume":"40","author":"Quinn","year":"2016","journal-title":"J Neurol Phys Ther"},{"key":"2023012004010694700_bib26","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1212\/WNL.0000000000004743","article-title":"Motor, cognitive, and functional declines contribute to a single progressive factor in early HD","volume":"89","author":"Schobel","year":"2017","journal-title":"Neurol"},{"key":"2023012004010694700_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Ann Intern Med"},{"author":"ICMJE","key":"2023012004010694700_bib28","article-title":"Recommendations"},{"key":"2023012004010694700_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0269215514540921","article-title":"Exercise testing and training in people with Huntington's disease","volume":"29","author":"Dawes","year":"2015","journal-title":"Clin Rehabil"},{"key":"2023012004010694700_bib30","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2522\/ptj.20130032","article-title":"Reliability and minimal detectable change of physical performance measures in individuals with pre-manifest and manifest Huntington disease","volume":"93","author":"Quinn","year":"2013","journal-title":"Phys Ther"},{"key":"2023012004010694700_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5334\/tohm.177","article-title":"HD-PRO-TRIADTM validation: a patient-reported instrument for the symptom triad of Huntington's disease","volume":"4","author":"Carlozzi","year":"2014","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"2023012004010694700_bib32","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1136\/bjsm.2004.014258","article-title":"Development and initial validation of the Brunel lifestyle physical activity questionnaire","volume":"39","author":"Karageorghis","year":"2005","journal-title":"Br J Sports Med"},{"key":"2023012004010694700_bib33","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1249\/MSS.0b013e31820513be","article-title":"Validation of the GENEA accelerometer","volume":"43","author":"Esliger","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"2023012004010694700_bib34","first-page":"A62","article-title":"F64 Wearable technologies for assessment of physical activity in HD: preliminary analysis of movement variability and wear time","volume":"89","author":"Poile","year":"2018","journal-title":"J Neurol Neurosurg Psyc"},{"key":"2023012004010694700_bib35","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sport Exerc"},{"key":"2023012004010694700_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/mds.26174","article-title":"A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease","volume":"30","author":"Reilmann","year":"2015","journal-title":"Mov Disord"},{"key":"2023012004010694700_bib37","first-page":"P2.005","article-title":"Efficacy, safety, and tolerabilty of pridopridinein Huntingtons Disease (HD). Results from the phase II, double-blind, placebo-controlled, dose-ranging study, PRIDE-HD (P2.005)","volume-title":"Neurology","author":"Kieburtz"},{"key":"2023012004010694700_bib38","first-page":"A62","article-title":"F63 Preliminary results from Q-MOTOR\/Q-COG analyses in the Repair-HD study","volume":"89","author":"Schubert","year":"2018","journal-title":"J Neurol Neurosurg Psych"},{"key":"2023012004010694700_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/anr.1780320107","article-title":"Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis","volume":"32","author":"Lorig","year":"1989","journal-title":"Arthritis Rheum"}],"container-title":["Physical Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ptj\/advance-article-pdf\/doi\/10.1093\/ptj\/pzz075\/28669715\/pzz075.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ptj\/article-pdf\/99\/9\/1201\/48791005\/ptj_99_9_1201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ptj\/article-pdf\/99\/9\/1201\/48791005\/ptj_99_9_1201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T04:02:04Z","timestamp":1674187324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ptj\/article\/99\/9\/1201\/5491339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ptj\/pzz075","relation":{},"ISSN":["0031-9023","1538-6724"],"issn-type":[{"type":"print","value":"0031-9023"},{"type":"electronic","value":"1538-6724"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,5,17]]}}}